A detailed history of Yousif Capital Management, LLC transactions in Genmab A/S stock. As of the latest transaction made, Yousif Capital Management, LLC holds 10,153 shares of GMAB stock, worth $209,050. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,153
Previous 10,531 3.59%
Holding current value
$209,050
Previous $264,000 6.44%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

SELL
$23.84 - $28.48 $9,011 - $10,765
-378 Reduced 3.59%
10,153 $247,000
Q2 2024

Jul 31, 2024

SELL
$25.13 - $30.27 $16,460 - $19,826
-655 Reduced 5.86%
10,531 $264,000
Q2 2023

Aug 02, 2023

BUY
$37.4 - $42.94 $7,255 - $8,330
194 Added 1.76%
11,186 $425,000
Q3 2022

Nov 04, 2022

BUY
$31.52 - $373.61 $28,052 - $332,512
890 Added 8.81%
10,992 $353,000
Q2 2022

Aug 01, 2022

SELL
$26.83 - $38.57 $1,878 - $2,699
-70 Reduced 0.69%
10,102 $328,000
Q4 2021

Jan 31, 2022

BUY
$35.87 - $47.12 $364,869 - $479,304
10,172 New
10,172 $402,000

Others Institutions Holding GMAB

About GENMAB A/S


  • Ticker GMAB
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 658,292,992
  • Market Cap $13.6B
  • Description
  • Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...
More about GMAB
Track This Portfolio

Track Yousif Capital Management, LLC Portfolio

Follow Yousif Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Yousif Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Yousif Capital Management, LLC with notifications on news.